Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMFORT-SHORT: OCT-Guided PCI and Short DAPT in Stable Angina
NCT07198529Recruiting
- Sponsor
- Korea University Guro Hospital
- Start
- Sep 2025
- Primary completion
- Sep 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of aspirin and clopidogrel in stable angina and coronary artery disease (CAD) (3 arms), sponsored by Korea University Guro Hospital. Primary endpoint: Net Adverse Cardiovascular Events at 12 months. Started Sep 2025; status: recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
stable anginacoronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07198529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07198529.